HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER

HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER

Prostate cancer (PC) is one of the most actual problems of modern oncourology. Hormone therapy (HT) using medical castration is the main method of treatment of patients with metastatic PC. HT with usage of the new class of drugs that block the receptors for luteinizing hormone releasing hormone (LHR...

Full description

Bibliographic Details
Main Authors: K. M. Nyushko, A. A. Krasheninnikov, M. P. Golovaschenko, A. D. Kaprin
Format: Article
Language:Russian
Published: QUASAR, LLC 2015-01-01
Series:Issledovaniâ i Praktika v Medicine
Subjects:
prostate cancer
analogues and antagonists of luteinizing hormone releasing hormone
the castration refractory
cardiovascular disease
cardiovascular risk.
Online Access:https://www.rpmj.ru/rpmj/article/view/20
id doaj-b1730cb38f904f869cb851d3f52b653c
record_format Article
spelling doaj-b1730cb38f904f869cb851d3f52b653c2021-08-02T08:54:19ZrusQUASAR, LLCIssledovaniâ i Praktika v Medicine2409-22312410-18932015-01-0111697310.17709/2409-2231-2014-1-1-69-7310HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCERK. M. Nyushko0A. A. Krasheninnikov1M. P. Golovaschenko2A. D. Kaprin3Moscow Oncology Institute of the Hertsen FMRC MH RF (Moscow, Russian Federation) 3, 2 B otkinskiy proezd, 125284, Russian Federation, MoscowMoscow Oncology Institute of the Hertsen FMRC MH RF (Moscow, Russian Federation) 3, 2 B otkinskiy proezd, 125284, Russian Federation, MoscowMoscow Oncology Institute of the Hertsen FMRC MH RF (Moscow, Russian Federation) 3, 2 B otkinskiy proezd, 125284, Russian Federation, MoscowHertsen FMRC MH RF (Obninsk, Russian Federation) 4, st. Korolev, 249036, Russian Federation, Kaluga region, ObninskProstate cancer (PC) is one of the most actual problems of modern oncourology. Hormone therapy (HT) using medical castration is the main method of treatment of patients with metastatic PC. HT with usage of the new class of drugs that block the receptors for luteinizing hormone releasing hormone (LHRH) is a promising and effective method of castration therapy that has a number of significant advantages over the use of analogues LHRH. This article presents areview of studies that compared the effectiveness and side effects of HT using antagonists and analogues LHRH.https://www.rpmj.ru/rpmj/article/view/20prostate canceranalogues and antagonists of luteinizing hormone releasing hormonethe castration refractorycardiovascular diseasecardiovascular risk.
collection DOAJ
language Russian
format Article
sources DOAJ
author K. M. Nyushko
A. A. Krasheninnikov
M. P. Golovaschenko
A. D. Kaprin
spellingShingle K. M. Nyushko
A. A. Krasheninnikov
M. P. Golovaschenko
A. D. Kaprin
HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
Issledovaniâ i Praktika v Medicine
prostate cancer
analogues and antagonists of luteinizing hormone releasing hormone
the castration refractory
cardiovascular disease
cardiovascular risk.
author_facet K. M. Nyushko
A. A. Krasheninnikov
M. P. Golovaschenko
A. D. Kaprin
author_sort K. M. Nyushko
title HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
title_short HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
title_full HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
title_fullStr HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
title_full_unstemmed HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
title_sort hormone therapy with usage of agonists and antagonists of luteinizing hormone releasing hormone in patients with prostate cancer
publisher QUASAR, LLC
series Issledovaniâ i Praktika v Medicine
issn 2409-2231
2410-1893
publishDate 2015-01-01
description Prostate cancer (PC) is one of the most actual problems of modern oncourology. Hormone therapy (HT) using medical castration is the main method of treatment of patients with metastatic PC. HT with usage of the new class of drugs that block the receptors for luteinizing hormone releasing hormone (LHRH) is a promising and effective method of castration therapy that has a number of significant advantages over the use of analogues LHRH. This article presents areview of studies that compared the effectiveness and side effects of HT using antagonists and analogues LHRH.
topic prostate cancer
analogues and antagonists of luteinizing hormone releasing hormone
the castration refractory
cardiovascular disease
cardiovascular risk.
url https://www.rpmj.ru/rpmj/article/view/20
work_keys_str_mv AT kmnyushko hormonetherapywithusageofagonistsandantagonistsofluteinizinghormonereleasinghormoneinpatientswithprostatecancer
AT aakrasheninnikov hormonetherapywithusageofagonistsandantagonistsofluteinizinghormonereleasinghormoneinpatientswithprostatecancer
AT mpgolovaschenko hormonetherapywithusageofagonistsandantagonistsofluteinizinghormonereleasinghormoneinpatientswithprostatecancer
AT adkaprin hormonetherapywithusageofagonistsandantagonistsofluteinizinghormonereleasinghormoneinpatientswithprostatecancer
_version_ 1721236992122945536

Similar Items